09 May 2018 Research
Sharing this exciting news: a treatment advance for childhood leukaemia
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades.
“We are excited at this breakthrough in the treatment for childhood leukaemia. CAR-T cell therapy gives those children who do not respond to chemotherapy treatment a real chance of a long-term cure. We welcome this significant step forward which will give hope to families whose children are affected by leukaemia.”
Dr Maria Gilleece, Director, Yorkshire Blood and Marrow Transplant Programme and a member of the Leukaemia UK Medical Panel.
Related posts
18 July 2021
Open letter from cancer charities to the public
40 charities and organisations have written an open letter, urging the public to help keep vulnerable people safe as restrictions ease.
4 April 2022
Leukaemia UK launches search for five new talented Trustees
We are looking for a talented and diverse set of Trustees to join our Board, and help guide the charity as we embark on an ambitious new strategy to accelerate progress in leukaemia research to stop leukaemia devastating lives.
19 June 2023
Leukaemia UK research paves the way for personalised lymphoma treatment
Despite promising trials, standard treatment for diffuse large B-cell lymphoma (DLBCL) hasn’t changed in a decade. New treatment strategies for this type of blood cancer are urgently needed. Could the…
11 January 2019
Lymphoma: Understanding relapse and treatment resistance
Dr Dinis Calado, The Francis Crick Institute and Project Grant Holder